Business · 19/09/2016Updated: 10/17/2026 · 1 min read
FDA Establishes Public Docket for Biomarker List
Summary
The FDA is seeking public input on a list of biomarkers used to develop FDA-approved new molecular entities and biological therapeutics from 2007 to 2015, with comments helping inform future biomarker databases.